Sara Ali is a clinical and translational researcher with expertise in epidemiology, clinical research, and cancer survivorship. She is currently pursuing her PhD on health outcomes among ovarian cancer survivors, with appointments at the University of Queensland and QIMR Berghofer Medical Research Institute. She previously completed Harvard Medical School's Introduction to Clinical Research Training program, gaining advanced knowledge in epidemiology, biostatistics, clinical trials, research ethics, and institutional review board (IRB) processes. Sara also holds a Master's degree in Physiology from Ain Shams University, Egypt. Her research experience spans clinical research operations, systematic reviews, data analysis using RStudio and Stata, scientific writing, peer review, and international conference presentations. Alongside her academic work, she has professional experience in clinical coordination and aged care, integrating research with patient-centered healthcare. Her work focuses on improving health outcomes and quality of life for cancer survivors through evidence-based, translational research.
Other Editorial Board Members
